PA
AES icon

PharVision Advisers’s AES AES Stock Holding History

PharVision Advisers’s Portfolio AES Stock Details AES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,625
Closed -$210K – 108
2025
Q4 		$210K Buy
+14,625
New +$206K 0.11% 517

Other funds holding AES

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

PharVision Advisers's AES Position: Q1 2026 in Review

PharVision Advisers sold out of AES (AES) in Q1 2026, closing a stake of 14,625 shares — an estimated $210K sold.

PharVision Advisers first reported a position in AES in Q4 2025 and held it in 1 quarter. The position peaked at $210K in Q4 2025. 747 funds tracked by Wall St. Rank hold AES as of Q1 2026.

  • PharVision Advisers reported no remaining AES position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 14,625 AES shares in Q1 2026, an estimated $210K.
  • PharVision Advisers first reported a position in AES in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's AES position peaked at $210K in Q4 2025.
  • 747 funds tracked by Wall St. Rank held AES as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.